Fatal interstitial pneumonitis related to rituximab-containing regimen

Clinical Lymphoma & Myeloma
Yair HerishanuElizabeth Naparstek

Abstract

Rituximab, a chimeric anti-CD20 monoclonal antibody, is commonly being used to treat indolent and aggressive B-cell non-Hodgkin's lymphoma. Rituximab is considered a relatively safe drug, but recently, severe and fatal adverse effects related to this drug have been reported. In this regard, we report an 80-year-old patient with follicular grade 3 non-Hodgkin's lymphoma who developed a fatal interstitial pneumonitis related to treatment with a rituximab/CHOP (cyclophosphamide/doxorubicin/vincristine/prednisone) regimen. The pneumonitis was diagnosed on a routine midtreatment positron emission tomography/computed tomography scan when the patient was almost asymptomatic. Pulmonary deterioration occurred as the treatment with rituximab/CHOP was continued. In this article, we also review the literature on rituximab-associated pneumonitis, and we discuss the differential diagnosis with cyclophosphamide-induced lung injury.

References

Dec 1, 1996·American Journal of Respiratory and Critical Care Medicine·S W MalikU Specks
Feb 15, 2002·British Journal of Haematology·L E van der KolkM H van Oers
Sep 7, 2002·American Journal of Hematology·Yair Herishanu
Nov 28, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S LowndesA Lister
Jun 27, 2003·The New England Journal of Medicine·Catherine BurtonRiaz Jan-Mohamed
Jun 27, 2003·The New England Journal of Medicine·Eric VoogPhilippe Solal-Céligny
Jan 30, 2004·Annual Review of Medicine·William RastetterChristine A White
Aug 13, 2004·American Journal of Hematology·R SwordsP T Murphy
Oct 30, 2004·Leukemia & Lymphoma·Doru T AlexandrescuPeter H Wiernik

❮ Previous
Next ❯

Citations

Apr 28, 2009·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Marie-Camille ChaumaisGeorges Deschênes
Nov 15, 2011·Targeted Oncology·Nicholas A Barber, Apar Kishor Ganti
Apr 15, 2008·International Journal of Hematology·Daisuke EnnishiKiyohiko Hatake
Dec 18, 2009·Anti-cancer Drugs·Maajid Mumtaz PeerzadaHamed A Daw
Jul 16, 2010·Clinical Nuclear Medicine·Bong-Il SongKyung-Min Shin
Dec 14, 2011·Rheumatology·Andreas V HadjinicolaouAndrew J K Ostör
Apr 29, 2009·Leukemia & Lymphoma·Ron RamPia Raanani
Dec 30, 2009·Leukemia & Lymphoma·C VulstekeP Schöffski
Aug 10, 2010·Clinics in Chest Medicine·Keith C MeyerRobert Baughman
Apr 22, 2008·Joint, Bone, Spine : Revue Du Rhumatisme·Huguette Lioté
Jul 11, 2012·Case Reports in Medicine·Ahmet B ErginHamed A Daw
Jan 23, 2013·Nature Reviews. Nephrology·Aditi Sinha, Arvind Bagga

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.